These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16878478)

  • 1. Pre-exposure rabies booster vaccinations: a literature review.
    Morris J; Crowcroft NS
    Dev Biol (Basel); 2006; 125():205-15. PubMed ID: 16878478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational lyssavirus risks and post-vaccination monitoring.
    Brookes SM; Fooks AR
    Dev Biol (Basel); 2006; 125():165-73. PubMed ID: 16878474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination.
    Morris J; Crowcroft NS; Fooks AR; Brookes SM; Andrews N
    Hum Vaccin; 2007; 3(5):165-70. PubMed ID: 17786037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
    Servat A; Wasniewski M; Cliquet F
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
    Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
    Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1.
    Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V
    Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of rabies vaccine strains to elicit cross-neutralising antibodies.
    Brookes SM; Healy DM; Fooks AR
    Dev Biol (Basel); 2006; 125():185-93. PubMed ID: 16878476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
    Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postexposure prophylaxis after bite of a broad-winged bat with evidence of European bat lyssavirus 1 (EBLV-1)].
    Fasse J; Trawinski H; Hardt M; Lübbert C
    Inn Med (Heidelb); 2024 Jun; 65(6):608-611. PubMed ID: 38100072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European bat lyssaviruses: an emerging zoonosis.
    Fooks AR; Brookes SM; Johnson N; McElhinney LM; Hutson AM
    Epidemiol Infect; 2003 Dec; 131(3):1029-39. PubMed ID: 14959767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies and other lyssavirus diseases.
    Warrell MJ; Warrell DA
    Lancet; 2004 Mar; 363(9413):959-69. PubMed ID: 15043965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans.
    Mansfield KL; Andrews N; Goharriz H; Goddard T; McElhinney LM; Brown KE; Fooks AR
    Vaccine; 2016 Nov; 34(48):5959-5967. PubMed ID: 27997343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veterinary surgeon's guide to Australian bat lyssavirus.
    Thompson GK
    Aust Vet J; 1999 Nov; 77(11):710-2. PubMed ID: 10685161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bat rabies surveillance in Europe.
    Schatz J; Fooks AR; McElhinney L; Horton D; Echevarria J; Vázquez-Moron S; Kooi EA; Rasmussen TB; Müller T; Freuling CM
    Zoonoses Public Health; 2013 Feb; 60(1):22-34. PubMed ID: 22963584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bat lyssavirus prophylaxis in an immunocompromised patient.
    Crome MA; McCall BJ; Selvey LA; Howard SM
    Med J Aust; 1998 Aug; 169(3):175. PubMed ID: 9734519
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus.
    Banyard AC; Selden D; Wu G; Thorne L; Jennings D; Marston D; Finke S; Freuling CM; Müller T; Echevarría JE; Fooks AR
    J Gen Virol; 2018 Dec; 99(12):1590-1599. PubMed ID: 29745870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V
    Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
    Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First isolation of a rabid bat infected with European bat lyssavirus in Luxembourg.
    Servat A; Herr J; Picard-Meyer E; Schley L; Harbusch C; Michaux C; Pir J; Robardet E; Engel E; Cliquet F
    Zoonoses Public Health; 2015 Feb; 62(1):7-10. PubMed ID: 24373212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic response to rabies pre-exposure vaccination in persons with potential occupational exposure in Singapore.
    Lim PL; Barkham TM
    Int J Infect Dis; 2010 Jun; 14(6):e511-3. PubMed ID: 20018545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.